Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Most people who received Rubraca maintenance therapy experienced tumor regression or had stable disease.
Talazoparib may offer an additional option for women with BRCA gene mutations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.